University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships

August 9, 2021 University of Oxford 0

Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded. Eleven new research projects have been announced today by the Irish Research Council and the Arts and Humanities Research Read More


Oxford vaccine reaches one billion doses released

July 30, 2021 University of Oxford 0

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on Read More


New book highlights life-saving role vaccines play in prevention of killer diseases

July 8, 2021 University of Oxford 0

‘Brain Fever’, a new book by internationally-renowned medical scientist Professor Richard Moxon, describes the decades of research that contribute to the development of vaccines for life-threatening illnesses such as meningitis, and how immunisation has been our greatest public health intervention. In ‘Brain Fever: How Vaccines Prevent Meningitis and Other Killer Read More


Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

July 1, 2021 University of Oxford 0

Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study. Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein Doses administered four weeks apart; data for 12-week dose interval due Read More


USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective

June 23, 2021 University of Oxford 0

– Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall – Vaccine 100% effective against severe or critical symptomatic COVID-19 – No safety concerns reported Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about the trial, please visit the Oxford COVID-19 Read More